635 related articles for article (PubMed ID: 24559509)
1. Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye.
Li Z; Choi JH; Oh HJ; Park SH; Lee JB; Yoon KC
Curr Eye Res; 2014 Sep; 39(9):871-8. PubMed ID: 24559509
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye.
Choi JH; Kim JH; Li Z; Oh HJ; Ahn KY; Yoon KC
Korean J Ophthalmol; 2015 Apr; 29(2):131-7. PubMed ID: 25829831
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of topical adiponectin in a mouse model of desiccating stress-induced dry eye.
Li Z; Woo JM; Chung SW; Kwon MY; Choi JS; Oh HJ; Yoon KC
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):155-62. PubMed ID: 23211823
[TBL] [Abstract][Full Text] [Related]
4. Effects of eye drops containing a mixture of 3% diquafosol sodium and tocopherol acetate (vitamin E) on the ocular surface of murine dry eye.
Li L; Jin R; Li Y; Yoon HS; Yoon HJ; Yoon KC
Cutan Ocul Toxicol; 2021 Dec; 40(4):350-358. PubMed ID: 34496685
[TBL] [Abstract][Full Text] [Related]
5. Effect of Topical 5-Aminoimidazole-4-carboxamide-1-β-d-Ribofuranoside in a Mouse Model of Experimental Dry Eye.
Sung MS; Li Z; Cui L; Choi JS; Choi W; Park MJ; Park SH; Yoon KC
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3149-58. PubMed ID: 26024098
[TBL] [Abstract][Full Text] [Related]
6. Effect of hypotonic 0.18% sodium hyaluronate eyedrops on inflammation of the ocular surface in experimental dry eye.
Oh HJ; Li Z; Park SH; Yoon KC
J Ocul Pharmacol Ther; 2014 Sep; 30(7):533-42. PubMed ID: 24766323
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of topical infliximab in a mouse model of experimental dry eye.
Li Z; Choi W; Oh HJ; Yoon KC
Cornea; 2012 Nov; 31 Suppl 1():S25-31. PubMed ID: 23038030
[TBL] [Abstract][Full Text] [Related]
8. Tear production and ocular surface changes in experimental dry eye after elimination of desiccating stress.
Yoon KC; Ahn KY; Choi W; Li Z; Choi JS; Lee SH; Park SH
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7267-73. PubMed ID: 21849424
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15 % and vitamin B12 eye drops.
Macri A; Scanarotti C; Bassi AM; Giuffrida S; Sangalli G; Traverso CE; Iester M
Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):425-30. PubMed ID: 25398660
[TBL] [Abstract][Full Text] [Related]
10. Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
Zhu L; Zhang C; Chuck RS
Mol Vis; 2012; 18():1803-12. PubMed ID: 22815633
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 0.1%, 0.18%, and 0.3% Hyaluronic Acid Eye Drops in the Treatment of Experimental Dry Eye.
You IC; Li Y; Jin R; Ahn M; Choi W; Yoon KC
J Ocul Pharmacol Ther; 2018 Oct; 34(8):557-564. PubMed ID: 30036099
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Efficacy of Topically Applied Antioxidant Medicinal Plant Extracts in a Mouse Model of Experimental Dry Eye.
Choi W; Lee JB; Cui L; Li Y; Li Z; Choi JS; Lee HS; Yoon KC
Oxid Med Cell Longev; 2016; 2016():4727415. PubMed ID: 27313829
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory Response to Lipopolysaccharide on the Ocular Surface in a Murine Dry Eye Model.
Simmons KT; Xiao Y; Pflugfelder SC; de Paiva CS
Invest Ophthalmol Vis Sci; 2016 May; 57(6):2443-51. PubMed ID: 27136463
[TBL] [Abstract][Full Text] [Related]
14. Topical omega-3 and omega-6 fatty acids for treatment of dry eye.
Rashid S; Jin Y; Ecoiffier T; Barabino S; Schaumberg DA; Dana MR
Arch Ophthalmol; 2008 Feb; 126(2):219-25. PubMed ID: 18268213
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Effect of Topical Adiponectin-Derived Short Peptides Compared with Globular Adiponectin in Experimental Dry Eye and Alkali Burn.
Li Y; Jin R; Li L; Hsu HH; You IC; Yoon HJ; Yoon KC
J Ocul Pharmacol Ther; 2020 Mar; 36(2):88-96. PubMed ID: 31661350
[No Abstract] [Full Text] [Related]
16. Evaluation of a Novel Artificial Tear in the Prevention and Treatment of Dry Eye in an Animal Model.
She Y; Li J; Xiao B; Lu H; Liu H; Simmons PA; Vehige JG; Chen W
J Ocul Pharmacol Ther; 2015 Nov; 31(9):525-30. PubMed ID: 26322539
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 0.3% Hypotonic and Isotonic Sodium Hyaluronate Eye Drops in the Treatment of Experimental Dry Eye.
Li Y; Cui L; Lee HS; Kang YS; Choi W; Yoon KC
Curr Eye Res; 2017 Aug; 42(8):1108-1114. PubMed ID: 28441078
[TBL] [Abstract][Full Text] [Related]
18. Effects of Quercetin in a Mouse Model of Experimental Dry Eye.
Oh HN; Kim CE; Lee JH; Yang JW
Cornea; 2015 Sep; 34(9):1130-6. PubMed ID: 26203745
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 0.025% FK-506, 0.05% Cyclosporin A, and 0.3% Sodium Hyaluronate Eye Drops for the Treatment of Botulinum Toxin B-Induced Mouse Dry Eye.
Lin BW; Huang WL; Wang L; Chen ZM
J Ocul Pharmacol Ther; 2018 Nov; 34(9):633-641. PubMed ID: 30227093
[TBL] [Abstract][Full Text] [Related]
20. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
